PB2100 MULTI‐BIOMARKER NORMALIZATION OF MM SERUM PATIENTS AS POSSIBLE GATEWAY FOR BONE MARROW MRD BY MULTIPARAMETER FLOW CYTOMETRY
Background: With the continuous development of more effective treatments and with new mechanisms of action leading to deeper responses of patients with Multiple Myeloma, the use of more sensitive tools to evaluate the effectiveness of treatments is required. Minimal residual disease by bone marrow m...
Saved in:
Published in: | HemaSphere Vol. 3; no. S1; pp. 946 - n/a |
---|---|
Main Authors: | , , |
Format: | Journal Article |
Language: | English |
Published: |
01-06-2019
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!